The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, overcomes resistance of human breast cancer cells to Apo2L/TRAIL. (Q40301695)
Jump to navigation
Jump to search
scientific article published on August 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, overcomes resistance of human breast cancer cells to Apo2L/TRAIL. |
scientific article published on August 2006 |
Statements
1 reference
The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, overcomes resistance of human breast cancer cells to Apo2L/TRAIL. (English)
1 reference
Lisa M Butler
1 reference
Vasilios Liapis
1 reference
Stelios Bouralexis
1 reference
Katie Welldon
1 reference
Shelley Hay
1 reference
Le M Thai
1 reference
Agatha Labrinidis
1 reference
Wayne D Tilley
1 reference
David M Findlay
1 reference
Andreas Evdokiou
1 reference
1 August 2006
1 reference
1 reference
119
1 reference
4
1 reference
944-954
1 reference
Identifiers
1 reference
1 reference